News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Sorrento Technologies, a biotech firm developing novel treatments for COVID-19 and aggressive cancers such as melanoma, has received FDA clearance to start a research collaboration together with Mayo Clinic.
Dispatches from Bio Digital 2021
Thermo Fisher announces a ‘completely redesigned’ solution to take potential therapies through to early-stage clinical trials.
The CDMO invests €58m in additional facility that will double the overall size of its production space.
Preliminary analysis of a large study of CureVac’s mRNA vaccine shows it is only 47% effective against COVID-19 disease of any severity.
DIA Annual Meeting 2021
In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently including COVID-19 vaccines.